H. Fainboim et al., Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study, J VIRAL HEP, 6(1), 1999, pp. 53-57
The objectives of this study were to investigate the prevalence of infectio
ns with hepatotrophic viruses in an anti-human immunodeficiency virus (HIV)
-positive population from Buenos Aires and to compare it among the main ris
k groups for HIV infection. Four hundred and eighty-four consecutive patien
ts attending the HIV outpatients clinic were studied: 359 men and 125 women
, median age 29 years (range 16-67 years); 35.5% had presented acquired imm
une deficiency syndrome (AIDS)-defining conditions, Two hundred and thirty-
four patients were intravenous drug users (IVDU), 99 had homosexual and 142
heterosexual preference, seven had received blood transfusions and two had
no risk factors, Hepatitis B surface antigen (HBsAg), and antibodies to he
patitis B core antigen (HBcAb) and to hepatitis C virus (anti-HCV) were inv
estigated in all patients: antibodies to HBsAg (HBsAb) and IgG antibodies t
o hepatitis D virus (anti-HDV) in all HBcAb-positive patients; hepatitis B
e antigen and antibodies to HBeAg (HBeAg) in all HBsAg-positive patients; I
gG antibodies to hepatitis A virus (anti-HAV) in the first 307 patients; an
d IgG antibodies to hepatitis E virus (anti-HEV) in the first 91 patients,
As control groups, contemporary voluntary blood donors were studied for pre
valence of HAV, HBV, HCV and HEV, The percentages of HBcAb, HBsAg, anti-HCV
and anti-HEV (58.5, 14.5, 58.5 and 6.6%, respectively) were significantly
higher in anti HIV-positive patients than in control groups (3.2, 0.5, 1.0
and 1.8%, respectively) (P = 0.000), The prevalence of HBcAb was significan
tly higher in IVDU (72.6%) than in heterosexuals (33.8%) (P = 0.0001) and i
n homosexuals (59.6%) (P = 0.0189). The percentage of HBsAg was significant
ly higher in IVDU (19.2%) than in heterosexuals (6.3%) (P = 0.0004). Anti-H
CV was significantly higher in IVDU (92.3%) than in homosexuals (14.1%) and
in heterosexuals (33.1%) (P = 0.000 in both cases), The prevalence of anti
-HDV was relatively low (1.9%), There was no difference in the percentage o
f anti-HIV between HIV-positive and negative subjects. In conclusion, there
is a high prevalence of HBV and HCV infections in HIV-positive patients fr
om our area. Drug use is the main route of transmission, but prevalence of
HCV in patients with, probably, sexually acquired HIV infection is also hig
her than in the control group. The increased prevalence of HEV infection in
HIV-positive individuals is another provocative finding that warrants furt
her study.